SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-09-062683
Filing Date
2009-11-16
Accepted
2009-11-16 08:43:16
Documents
5
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c92592e10vq.htm 10-Q 267767
2 EXHIBIT 31.1 c92592exv31w1.htm EX-31.1 9115
3 EXHIBIT 31.2 c92592exv31w2.htm EX-31.2 9111
4 EXHIBIT 32.1 c92592exv32w1.htm EX-32.1 3786
5 EXHIBIT 32.2 c92592exv32w2.htm EX-32.2 3775
  Complete submission text file 0000950123-09-062683.txt   295099
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15070 | Film No.: 091183811
SIC: 2834 Pharmaceutical Preparations